US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

710.58

+24.843.62%

Number of Gainers:84

Number of Losers:59

Number of Flat:11

PE:- -

High:710.84

Open:685.68

Low:683.13

Close:685.75

Volume:329.26M

Turnover:10.37B

Market Cap:495.36B

Float Cap:376.11B

Loading ...

Coinbase: Usdc Deposits, Withdrawals Remain Available on Other Supported Networks, Including Ethereum, Base, Solana, Arbitrum, Optimism, Polygon

THOMSON REUTERS

Silver Lake trims First Advantage stake in offering

Atea Pharmaceuticals Q2 Loss Narrows as HCV Trial Expenses Decline

MaxCyte Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

LifeStance COO Lisa K. Miller Disposes of 47,912 Common Shares Worth $519,245.20

MaxCyte Reports Q2 Results, Highlights Genentech Partnership

Allogene Therapeutics Q2 Loss Narrows

MT Newswires Live

Cardiol Therapeutics Reports Second-Quarter 2026 Interim Results

Logistic Properties of the Americas Posts Strong Midyear Valuation Gains in Latest SEC Filing

Outlook Therapeutics Ends ATM Prospectus Amid Ongoing Risks

Analysts Are Bullish on Top Healthcare Stocks: Monopar Therapeutics Inc (MNPR), AbSci (ABSI)

Press Release: Turn Therapeutics Provides Corporate Updates and Reports Second Quarter 2026 Financial Results

Robinhood Publishes July 2026 Monthly Metrics Report

Logistic Properties of the Americas Announces Second Quarter 2026 Earnings Results

THOMSON REUTERS

Sera Prognostics Q2 Revenue Rises on Expanded Partnerships and Medicaid Coverage

Bowman Consulting Director Patricia Mulroy Disposes of 883 Common Shares Worth $37,422.36

Logistic Properties of the Americas Q2 FY26 Profit Rises to USD 14.26 Million; Revenue Increases 26.09% to USD 14.74 Million

Erasca Files Form 3 for President, R&D Charles S. Fuchs

MaxCyte Publishes Corporate Presentation on Scalable Electroporation Platform for Cell and Gene Therapies

Oncology Device Maker RenovoRx's Q2 Revenue Surges, Raises FY Outlook

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/BK4539/news?page=44"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":710.5842,"timestamp":1787687999999,"preClose":685.7458,"halted":0,"volume":329259151,"delay":0,"changeRate":0.036221,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":24.83844,"latestTime":"08-25 16:00:00 EDT","open":685.6775,"high":710.84143,"low":683.1322,"amount":10370226198.826471,"amplitude":0.040407,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787731200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.436531,"peRate":156.391987,"turnoverRate":0.025545,"increases":84,"decrements":59,"flats":8,"marketCap":495359143396.625,"floatMarketCap":376108388528.9375},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":710.84143,"amplitude":0.040407,"preClose":685.7458,"low":683.1322,"pbRate":"5.436531","latestPrice":710.5842,"volume":329259151,"delay":0,"open":685.6775,"prevYearClose":881.5255,"prevWeekClose":700.9769,"prevMonthClose":673.0273,"prevQuarterClose":742.922,"fiveDayClose":655.4622,"twentyDayClose":704.4272,"sixtyDayClose":779.4826,"secType":"PLATE","market":"US","turnoverRate":0.025545,"peRate":156.391987,"marketCap":495359143396.625,"floatMarketCap":376108388528.9375,"timestamp":1787687999999,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":84,"down":59,"flat":11},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:44,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659185822","title":"Coinbase: Usdc Deposits, Withdrawals Remain Available on Other Supported Networks, Including Ethereum, Base, Solana, Arbitrum, Optimism, Polygon","url":"https://stock-news.laohu8.com/highlight/detail?id=2659185822","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659185822?lang=en_us&edition=fundamental","pubTime":"2026-08-13 05:35","pubTimestamp":1786570540,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN4491D8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["COYY","LU1861558580.USD","ICOI","FINX","COIG","LU1861559042.SGD","FDIG","BLCK","BK4554","BK4600","LU1791807156.HKD","CRCA","ICRC","CCUP","COII","LU1668664300.SGD","LU1861220207.SGD","COIA","BK4551","CRCO","LU1861217088.USD","LU2360107671.USD","BK4535","COIW","COIO","BKCH","CONI","CRCG","BK4596","BK4539","FIAT","SOL.USD.HKCC","CONX","CONL","LU0106831901.USD","IBLC","BK4595","BK4112","BK4516","CRPT","DAPP","CONY","BK4585","BK4588","BITQ","COIN","BK4023","CRCL","CRCD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659185697","title":"Silver Lake trims First Advantage stake in offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2659185697","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659185697?lang=en_us&edition=fundamental","pubTime":"2026-08-13 05:29","pubTimestamp":1786570173,"startTime":"0","endTime":"0","summary":"An update from First Advantage ( ($FA) ) is now available. On August 10, 2026, First Advantage Corporation announced that investment funds affiliat...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/silver-lake-trims-first-advantage-stake-in-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/silver-lake-trims-first-advantage-stake-in-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4535","FA","BK4130","SETM","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659183799","title":"Atea Pharmaceuticals Q2 Loss Narrows as HCV Trial Expenses Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2659183799","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659183799?lang=en_us&edition=fundamental","pubTime":"2026-08-13 05:28","pubTimestamp":1786570080,"startTime":"0","endTime":"0","summary":"Atea Pharmaceuticals Q2 loss narrows as HCV trial expenses declineOverviewUS antiviral drug developer reported Q2 net loss per share narrowed from prior yearR&D and admin expenses declined, reflecting","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL1N449163:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVIR","BK4007","BK4139","ABUS","TCRX","ENTA","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659183891","title":"MaxCyte Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2659183891","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659183891?lang=en_us&edition=fundamental","pubTime":"2026-08-13 05:02","pubTimestamp":1786568534,"startTime":"0","endTime":"0","summary":"MaxCyte Inc reports results for the quarter ended June 30 - Earnings SummaryMaxCyte IncMXCT.OQreported a quarterly adjusted loss of 8 cents per share for the quarter ended June 30, higher than the sam","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL8N44926U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MXCT","BK4539","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659188032","title":"LifeStance COO Lisa K. Miller Disposes of 47,912 Common Shares Worth $519,245.20","url":"https://stock-news.laohu8.com/highlight/detail?id=2659188032","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659188032?lang=en_us&edition=fundamental","pubTime":"2026-08-13 05:00","pubTimestamp":1786568426,"startTime":"0","endTime":"0","summary":"LifeStance COO Lisa K. Miller disposes of 47,912 common shares worth $519,245.20LifeStance Health COO Lisa K. Miller sold 47,912 common shares on Aug. 10 at USD 10.85.Direct holding fell to 281,289 sh","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL98VmhP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"LifeStance COO Lisa K. Miller Disposes of 47,912 Common Shares Worth $519,245.20","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FMED","BK4535","BK4539","LFST","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659838931","title":"MaxCyte Reports Q2 Results, Highlights Genentech Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2659838931","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659838931?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:57","pubTimestamp":1786568277,"startTime":"0","endTime":"0","summary":"An announcement from MaxCyte ( ($MXCT) ) is now available. On August 12, 2026, MaxCyte reported second‑quarter 2026 revenue of $7.3 million, down 1...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/maxcyte-reports-q2-results-highlights-genentech-partnership?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/maxcyte-reports-q2-results-highlights-genentech-partnership?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MXCT","BK4539","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659882701","title":"Allogene Therapeutics Q2 Loss Narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2659882701","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659882701?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:57","pubTimestamp":1786568264,"startTime":"0","endTime":"0","summary":"Allogene Therapeutics (ALLO) reported a Q2 loss late Wednesday of $0.13 per diluted share, narrowing from a loss of $0.23 a year earlier.Collaboration revenue for the three months ended June 30 was $4","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALLO","BK4139","BK4007","LENZ","BK4539","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659359183","title":"Cardiol Therapeutics Reports Second-Quarter 2026 Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659359183","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659359183?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:48","pubTimestamp":1786567723,"startTime":"0","endTime":"0","summary":"Cardiol Therapeutics ( ($TSE:CRDL) ) just unveiled an update. Cardiol Therapeutics filed a Form 6-K on August 12, 2026, reporting unaudited condens...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cardiol-therapeutics-reports-second-quarter-2026-interim-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cardiol-therapeutics-reports-second-quarter-2026-interim-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LENZ","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659833111","title":"Logistic Properties of the Americas Posts Strong Midyear Valuation Gains in Latest SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2659833111","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659833111?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:47","pubTimestamp":1786567660,"startTime":"0","endTime":"0","summary":"Logistic Properties of the Americas ( ($LPA) ) has shared an announcement. On August 12, 2026, Logistic Properties of the Americas filed a Form 6-K...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/logistic-properties-of-the-americas-posts-strong-midyear-valuation-gains-in-latest-sec-filing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/logistic-properties-of-the-americas-posts-strong-midyear-valuation-gains-in-latest-sec-filing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","LPA","BK4233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659926188","title":"Outlook Therapeutics Ends ATM Prospectus Amid Ongoing Risks","url":"https://stock-news.laohu8.com/highlight/detail?id=2659926188","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659926188?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:37","pubTimestamp":1786567029,"startTime":"0","endTime":"0","summary":"The latest update is out from Outlook Therapeutics ( ($OTLK) ). On July 24, 2026, Outlook Therapeutics announced U.S. FDA approval of LYTENAVA (bev...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/outlook-therapeutics-ends-atm-prospectus-amid-ongoing-risks?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/outlook-therapeutics-ends-atm-prospectus-amid-ongoing-risks?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GDOC","GNMX","BK4139","IDNA","FRTY","TECB","NVIB","IBB","LENZ","IEIH","IYH","MRNX","XLVX","BMED","BK4007","RSPH","LFSC","MRNY","BK4585","LABU","SYNB","BBP","PSCH","TBXU","MEDI","PINK","BK4539","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659018860","title":"Analysts Are Bullish on Top Healthcare Stocks: Monopar Therapeutics Inc (MNPR), AbSci (ABSI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659018860","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659018860?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:30","pubTimestamp":1786566610,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Monopar Therapeutics Inc (MNPR) and AbSci (ABSI) wit...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-monopar-therapeutics-inc-mnpr-absci-absi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-monopar-therapeutics-inc-mnpr-absci-absi-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABSI","MNPR","BK4139","ARKG","BK4121","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659900040","title":"Press Release: Turn Therapeutics Provides Corporate Updates and Reports Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659900040","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659900040?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:30","pubTimestamp":1786566600,"startTime":"0","endTime":"0","summary":"Interim Analysis Supports Expansion of GX-03 Phase 2 Study to a Broader Population of Atopic Dermatitis Patients, Including Patients with Moderate-to-Severe Lesions but Lower Overall Disease ExtentDr.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","LENZ","EASI","TTRX","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659290008","title":"Robinhood Publishes July 2026 Monthly Metrics Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2659290008","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659290008?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:29","pubTimestamp":1786566551,"startTime":"0","endTime":"0","summary":"Robinhood publishes July 2026 monthly metrics reportRobinhood released its July 2026 monthly metrics report, showing funded customers at 28.5 million, up 7% year over year.Total platform assets were U","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL1BmMfL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HOYY","LU1861558580.USD","CRPT","HODU","HOOY","BK4127","BK4547","FINX","HOII","BK4539","BLCK","HOOD","IAI","HOOW","HOOG","ROBN","HOOX","BPAY","HOOZ","HOOI","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659190070","title":"Logistic Properties of the Americas Announces Second Quarter 2026 Earnings Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659190070","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659190070?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:29","pubTimestamp":1786566540,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nTUA3QVN2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LPA","BK4233","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659900726","title":"Sera Prognostics Q2 Revenue Rises on Expanded Partnerships and Medicaid Coverage","url":"https://stock-news.laohu8.com/highlight/detail?id=2659900726","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659900726?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:28","pubTimestamp":1786566507,"startTime":"0","endTime":"0","summary":"Sera Prognostics Q2 revenue rises on expanded partnerships and Medicaid coverageOverviewUS pregnancy diagnostics firm's Q2 revenue rose yr/yr, driven by expanded partnerships and Medicaid coverageComp","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL1N44912X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z6F94.USD","LU2237957811.SGD","SERA","IE0034390439.USD","QTRX","TECH","BCDA","IE00B64QTZ34.USD","BK4588","LU0205194284.USD","BK4585","BK4139","BK4539","BK4121","LU2237957902.USD","LU0205193047.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659490075","title":"Bowman Consulting Director Patricia Mulroy Disposes of 883 Common Shares Worth $37,422.36","url":"https://stock-news.laohu8.com/highlight/detail?id=2659490075","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659490075?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:26","pubTimestamp":1786566413,"startTime":"0","endTime":"0","summary":"Bowman Consulting director Patricia Mulroy disposes of 883 common shares worth $37,422.36Bowman Consulting Group director Patricia Mulroy sold 883 common shares on Aug. 10, 2026 at USD 42.37.Direct ho","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL8cGbjb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Bowman Consulting Director Patricia Mulroy Disposes of 883 Common Shares Worth $37,422.36","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4129","BK4539","BWMN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659900228","title":"Logistic Properties of the Americas Q2 FY26 Profit Rises to USD 14.26 Million; Revenue Increases 26.09% to USD 14.74 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659900228","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659900228?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:24","pubTimestamp":1786566279,"startTime":"0","endTime":"0","summary":"Logistic Properties of the Americas Q2 FY26 profit rises to USD 14.26 million; revenue increases 26.09% to USD 14.74 millionLogistic Properties of the Americas swung to profit of USD 14.26 million in ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL57DtYJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","LPA","BK4233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659900401","title":"Erasca Files Form 3 for President, R&D Charles S. Fuchs","url":"https://stock-news.laohu8.com/highlight/detail?id=2659900401","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659900401?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:22","pubTimestamp":1786566129,"startTime":"0","endTime":"0","summary":"Erasca files Form 3 for President, R&D Charles S. FuchsErasca filed an initial beneficial ownership statement for Charles S. Fuchs, its president of R&D, dated Aug. 10.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Erasca Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 12, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL8Dtx1h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","ERAS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659900104","title":"MaxCyte Publishes Corporate Presentation on Scalable Electroporation Platform for Cell and Gene Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2659900104","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659900104?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:21","pubTimestamp":1786566108,"startTime":"0","endTime":"0","summary":"MaxCyte publishes corporate presentation on scalable electroporation platform for cell and gene therapiesMaxCyte outlined its cell-engineering platform strategy focused on non-viral electroporation fo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL1VwGWC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","MXCT","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659900195","title":"Oncology Device Maker RenovoRx's Q2 Revenue Surges, Raises FY Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2659900195","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659900195?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:20","pubTimestamp":1786566051,"startTime":"0","endTime":"0","summary":"Oncology device maker RenovoRx's Q2 revenue surges, raises FY outlookOverviewTargeted oncology device maker's Q2 2026 revenue rose 115% yr/yr to record $909,000Company raised full-year 2026 revenue gu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL1N44911Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMNM","BK4539","BK4082","BK4588","ICCM","MEDI","MEMS","LEGN","BK4585","CANC","BK4563","RNXT","BK4505","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":51,"pageCount":44,"totalSize":1010,"code":"91000000","status":"200"}]}}